Senate User Fee Bill Heads To Mark-up Without Track-And-Trace
This article was originally published in The Pink Sheet Daily
Executive Summary
Manager’s amendment released in lead-up to committee mark-up still does not include drug tracking provisions, but will expand advisory committee recruiting and eliminate conflict of interest waivers using language in Rep. Burgess’ bill.